Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics
Anna H Ou1, Sara B Rosenthal2, Mazda Adli3,4
1Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Abstract:
Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study of the Pharmacogenomics of Bipolar Disorder (PGBD) sample combining transcriptomic and genomic data, we found that focal adhesion, the extracellular matrix (ECM), and PI3K-Akt signaling networks were associated with response to lithium. In this study, we replicated the results of our previous study using network propagation methods in a genome-wide association study of an independent sample of 2039 patients from the International Consortium on Lithium Genetics (ConLiGen) study. We identified functional enrichment in focal adhesion and PI3K-Akt pathways, but we did not find an association with the ECM pathway. Our results suggest that deficits in the neuronal growth cone and PI3K-Akt signaling, but not in ECM proteins, may influence response to lithium in BD.
Related Concept Videos
Mania and Antimanic Drugs: Overview
PI3K/mTOR/AKT Signaling Pathway
Bipolar Disorder
Intracellular Signaling Affects Focal Adhesions
Some...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Anchoring Junctions


